封面
市場調查報告書
商品編碼
1829374

2025年全球安全注射器市場報告

Safety Syringe Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,安全注射器市場規模強勁成長,從2024年的89.5億美元增加至2025年的96.8億美元,複合年成長率達8.1%。這段時期的成長歸因於對針刺傷的擔憂、監管要求的加強、安全措施的不斷推行、血源性疾病盛行率的上升以及醫療基礎設施的不斷完善。

預計未來幾年安全注射器市場規模將強勁成長,到2029年將達到135.5億美元,年複合成長率(CAGR)為8.8%。預測期內的成長可歸因於疫苗接種工作、老年人口的成長、對預防性醫療保健的日益重視、生物製藥行業的擴張以及材料科學的進步。預測期內的主要趨勢包括快速的技術創新、對永續解決方案的重視、與遠端醫療的整合、專科治療方法的客製化解決方案以及增強的緊急應變和準備能力。

安全注射器是一種整合安全功能的醫用注射器,可減輕意外針刺傷並防止重複使用。這些注射器專為幫助醫護人員和個人避免因使用過的針頭意外刺穿皮膚而造成的針刺傷而設計。

安全注射器主要分為可伸縮式和非伸縮式安全注射器。可伸縮式安全注射器內建機構,可在注射後將針頭縮回或拉回注射器針筒。它們適用於皮下和肌肉注射胰島素、胰高血糖素類升糖素肽-1 (GLP-1)、結核病和生長激素治療。這類注射器廣泛應用於各種醫療機構,包括醫院、門診手術中心、長期照護機構和專科診所。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供安全注射器市場統計數據,例如全球市場規模、區域佔有率、競爭對手的安全注射器市場佔有率、詳細的安全注射器細分市場、市場趨勢和商業機會,為您提供在安全注射器行業取得成功所需的數據。本安全注射器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。

未來五年的預測成長率為8.8%,較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間的關稅影響。這項影響將直接影響美國,導致主要從巴西和印度進口的自動失效推桿和針頭護罩組件成本上升,進而影響疫苗接種計畫和疫苗接種管理。

預計血液傳染疾病的日益普及將推動未來安全注射器市場的成長。血液傳染疾病是由經由血液傳播的細菌、病毒和寄生蟲等微生物引起的感染疾病。安全注射器作為一種預防措施,可以保護醫護人員和患者免於接觸血源性病原體,從而減少意外感染的可能性並支持醫療程序中的最佳實踐。例如,2024 年 4 月,總部位於瑞士的政府間組織世界衛生組織 (WHO) 報告稱,2022 年將有大約 2.54 億人感染慢性乙型肝炎,每年新增感染病例 120 萬例。同年估計死亡人數為 110 萬,主要原因是肝硬化和肝細胞癌(原發性肝癌)。此外,全球約有 5,000 萬人感染慢性C型肝炎感染疾病,每年新增病例約 100 萬例。 2022年,C型肝炎導致約24.2萬人死亡,主要死因是肝硬化和原發性肝癌。因此,血液傳播疾病的增加刺激了對安全注射器的需求。

為了提升市場競爭力,主要企業正推出玻璃疫苗注射器等創新產品。玻璃疫苗注射器是一種用於給患者注射疫苗的玻璃醫療設備,為給藥提供了一種無菌、可重複使用的方案。例如,2022年9月,美國醫療設備製造商碧迪公司(Becton Dickinson)推出了BD Effivax玻璃預灌封注射器。這款預灌封注射器專為提高藥物傳遞系統(尤其是疫苗)的安全性和可靠性而設計。它專為精準給藥而設計,解決了製備和給藥過程中對污染和產品完整性的擔憂。設計和製造流程的進步降低了傳統管瓶的風險,顯著提高了患者在疫苗接種過程中的安全性。

2022年7月,總部位於美國的醫療設備公司Sharps Technology以250萬美元的價格收購了SafeGard Medical位於匈牙利的注射器製造工廠。此次策略性收購旨在增強Sharps Technology的製造能力,加速其向收益商業營運的轉型,並滿足全球取得專利的智慧安全注射器日益成長的需求。 SafeGard Medical也總部位於美國,專注於緊急醫療技術和培訓,包括安全注射器的製造。

安全注射器市場涵蓋伸縮式注射器、無針注射器、安全注射器配件、取針器和採血設備的銷售。該市場的價值為“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球安全注射器:PESTEL分析(政治、社會、科技、環境、法律因素、促進因素與限制因素)
  • 最終用途產業分析
  • 全球安全注射器市場:成長率分析
  • 全球安全注射器市場表現:規模與成長,2019-2024
  • 全球安全注射器市場預測:規模與成長,2024-2029年,2034年
  • 全球安全注射器:總目標市場(TAM)

第6章 市場細分

  • 全球安全注射器市場:依產品、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 伸縮式安全注射器
  • 不可伸縮式安全注射器
  • 全球安全注射器市場:依療法、實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 胰島素
  • 類升糖素肽-I(CLP-I)
  • 結核
  • 生長激素
  • 全球安全注射器市場:按應用、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 皮下
  • 肌肉注射
  • 全球安全注射器市場:按最終用戶、實際和預測,2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 長期照護機構
  • 專科診所
  • 其他最終用戶
  • 全球安全注射器市場:伸縮式安全注射器細分(按類型)、實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 自動伸縮式安全注射器
  • 手動伸縮式安全注射器
  • 全球安全注射器市場:不可伸縮式安全注射器細分(按類型)、實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 固定針頭安全注射器
  • 屏蔽針安全注射器

第7章 區域和國家分析

  • 全球安全注射器市場:按地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球安全注射器市場:依國家、績效及預測(2019-2024 年、2024-2029 年及 2034 年)

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章:西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 安全注射器市場:競爭格局
  • 安全注射器市場:公司簡介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Retractable Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Novo Nordisk A/s Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Medline Industries LP
  • Terumo Corporation
  • B. Braun Melsungen AG
  • West Pharmaceutical Services Inc.
  • Fresenius Kabi AG
  • Nemera
  • Smiths Medical International Ltd.
  • Nipro Medical Corporation
  • Henke-Sass Wolf GmbH
  • Revolutions Medical Inc.
  • Sol-Millennium Inc.
  • UltiMed Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章:高潛力市場國家、細分市場與策略

  • 2029年安全注射器市場:提供新機會的國家
  • 2029年安全注射器市場:細分市場帶來新機會
  • 2029年安全注射器市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r28926u

A safety syringe serves as a medical injection device equipped with integrated safety features to mitigate accidental needle stick injuries or reuse. These syringes are specifically engineered to avert needle stick injuries, which may occur when healthcare workers or individuals inadvertently puncture their skin with a used needle.

Safety syringes primarily comprise retractable safety syringes and non-retractable safety syringes. Retractable safety syringes feature a built-in mechanism enabling the needle to retract or withdraw into the syringe barrel post-injection. They find application in therapies such as insulin, glucagon-like peptide-i (GLP-1), tuberculosis, and growth hormones, catering to subcutaneous and intramuscular administration. These syringes are utilized across various healthcare settings including hospitals, ambulatory surgical centers, long-term care facilities, specialty clinics, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The safety syringe market research report is one of a series of new reports from The Business Research Company that provides safety syringe market statistics, including safety syringe industry global market size, regional shares, competitors with safety syringe market share, detailed safety syringe market segments, market trends, and opportunities, and any further data you may need to thrive in the safety syringe industry. This safety syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The safety syringe market size has grown strongly in recent years. It will grow from $8.95 billion in 2024 to $9.68 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to needlestick injury concerns, regulatory mandates, increased adoption of safety measures, increasing prevalence of blood-borne diseases, growing healthcare infrastructure.

The safety syringe market size is expected to see strong growth in the next few years. It will grow to $13.55 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to vaccination initiatives, rising geriatric population, increased focus on preventive healthcare, expanding biopharmaceutical industry, advancements in material sciences. Major trends in the forecast period include rapid technological innovations, emphasis on sustainable solutions, telehealth integration, customized solutions for specialized therapeutics, enhanced emergency response and preparedness.

The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher expenses for auto-disable plungers and needle-shielding components, largely imported from Brazil and India, affecting vaccination programs and medication administration.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of blood-borne diseases is expected to drive the growth of the safety syringe market in the future. Blood-borne diseases are infectious conditions caused by microorganisms like bacteria, viruses, or parasites transmitted through the blood. Safety syringes serve as a preventive measure to safeguard healthcare workers and patients from exposure to blood-borne pathogens, thereby reducing the chances of accidental infections and supporting best practices in medical procedures. For instance, in April 2024, the World Health Organization, a Switzerland-based intergovernmental agency, reported that approximately 254 million people were living with chronic hepatitis B infection in 2022, with 1.2 million new cases annually. The disease was responsible for an estimated 1.1 million deaths that year, largely due to cirrhosis and hepatocellular carcinoma (primary liver cancer). Additionally, about 50 million people globally are affected by chronic hepatitis C virus infection, with around 1 million new cases each year. In 2022, hepatitis C led to approximately 242,000 deaths, mainly due to cirrhosis and primary liver cancer. Consequently, the rise in blood-borne diseases is fueling the demand for safety syringes.

Leading companies in the safety syringe market are introducing innovative products, such as glass vaccine syringes, to enhance their competitive position. A glass vaccine syringe is a medical device made from glass, used for delivering vaccines to patients, providing a sterile and reusable option for medication administration. For example, in September 2022, Becton, Dickinson, and Company, a US-based medical device manufacturer, launched the BD Effivax Glass Prefillable Syringe. These prefillable syringes are specifically designed to improve the safety and reliability of drug delivery systems, especially for vaccines. Crafted to ensure accurate medication dosing, they address contamination and product integrity concerns during preparation and administration. Advances in design and manufacturing processes help mitigate risks associated with traditional vial formats, significantly enhancing patient safety in vaccine administration.

In July 2022, Sharps Technology Inc., a medical device company headquartered in the United States, completed the acquisition of a syringe manufacturing facility located in Hungary from SafeGard Medical for $2.5 million. This strategic acquisition is geared towards strengthening Sharps Technology's manufacturing capacities, facilitating the company's transition into revenue-generating commercial activities, and addressing the increasing worldwide demand for its patented smart safety syringes. SafeGard Medical, also based in the US, specializes in emergency medical technologies and training, including the production of safety syringes.

Major companies operating in the safety syringe market report are Cardinal Health Inc., Retractable Technologies Inc., Thermo Fisher Scientific Inc., Medtronic plc, Novo Nordisk A/s, Becton, Dickinson and Company, Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, West Pharmaceutical Services Inc., Fresenius Kabi AG, Nemera, Smiths Medical International Ltd., Nipro Medical Corporation, Henke-Sass Wolf GmbH, Revolutions Medical Inc., Sol-Millennium Inc., UltiMed Inc., Unilife Corporation, AdvaCare Pharma, Axol Bio Corporation, Vita Needle Company, Numedico Technologies Pty Ltd., Duopross Meditech Corporation, DMC Medical Ltd., Guangdong Haiou Medical Apparatus Co. Ltd., Kendall Healthcare Group Ltd.

North America was the largest region in the safety syringes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the safety syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The safety syringe market consists of sales of retractable syringes, needleless syringes, safety syringe accessories, needle removers and blood collection devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Safety Syringe Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on safety syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for safety syringe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The safety syringe market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Retractable Safety Syringes; Non Retractable Safety Syringes
  • 2) By Therapy: Insulin; Glucagon-like peptide-I (CLP-I); Tuberculosis; Growth Hormones
  • 3) By Application: Subcutaneous; Intramuscular
  • 4) By End-user: Hospitals; Ambulatory Surgical Centers; Long-term Care Facilities; Specialty Clinics; Other End Users
  • Subsegments:
  • 1) By Retractable Safety Syringes: Automatic Retractable Safety Syringes; Manual Retractable Safety Syringes
  • 2) By Non-Retractable Safety Syringes: Fixed Needle Safety Syringes; Shielded Needle Safety Syringes
  • Companies Mentioned: Cardinal Health Inc.; Retractable Technologies Inc.; Thermo Fisher Scientific Inc.; Medtronic plc; Novo Nordisk A/s; Becton, Dickinson and Company; Baxter International Inc.; Boston Scientific Corporation; Medline Industries LP; Terumo Corporation; B. Braun Melsungen AG; West Pharmaceutical Services Inc.; Fresenius Kabi AG; Nemera; Smiths Medical International Ltd.; Nipro Medical Corporation; Henke-Sass Wolf GmbH; Revolutions Medical iNC.; Sol-Millennium Inc.; UltiMed Inc.; Unilife Corporation; AdvaCare Pharma; Axol Bio Corporation; Vita Needle Company; Numedico Technologies Pty Ltd.; Duopross Meditech Corporation; DMC Medical Ltd.; Guangdong Haiou Medical Apparatus Co. Ltd.; Kendall Healthcare Group Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Safety Syringe Market Characteristics

3. Safety Syringe Market Trends And Strategies

4. Safety Syringe Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Safety Syringe Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Safety Syringe PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Safety Syringe Market Growth Rate Analysis
  • 5.4. Global Safety Syringe Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Safety Syringe Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Safety Syringe Total Addressable Market (TAM)

6. Safety Syringe Market Segmentation

  • 6.1. Global Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retractable Safety Syringes
  • Non Retractable Safety Syringes
  • 6.2. Global Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin
  • Glucagon-like peptide-I (CLP-I)
  • Tuberculosis
  • Growth Hormones
  • 6.3. Global Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Subcutaneous
  • Intramuscular
  • 6.4. Global Safety Syringe Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Long-term Care Facilities
  • Specialty Clinics
  • Other End Users
  • 6.5. Global Safety Syringe Market, Sub-Segmentation Of Retractable Safety Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automatic Retractable Safety Syringes
  • Manual Retractable Safety Syringes
  • 6.6. Global Safety Syringe Market, Sub-Segmentation Of Non-Retractable Safety Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fixed Needle Safety Syringes
  • Shielded Needle Safety Syringes

7. Safety Syringe Market Regional And Country Analysis

  • 7.1. Global Safety Syringe Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Safety Syringe Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Safety Syringe Market

  • 8.1. Asia-Pacific Safety Syringe Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Safety Syringe Market

  • 9.1. China Safety Syringe Market Overview
  • 9.2. China Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Safety Syringe Market

  • 10.1. India Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Safety Syringe Market

  • 11.1. Japan Safety Syringe Market Overview
  • 11.2. Japan Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Safety Syringe Market

  • 12.1. Australia Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Safety Syringe Market

  • 13.1. Indonesia Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Safety Syringe Market

  • 14.1. South Korea Safety Syringe Market Overview
  • 14.2. South Korea Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Safety Syringe Market

  • 15.1. Western Europe Safety Syringe Market Overview
  • 15.2. Western Europe Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Safety Syringe Market

  • 16.1. UK Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Safety Syringe Market

  • 17.1. Germany Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Safety Syringe Market

  • 18.1. France Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Safety Syringe Market

  • 19.1. Italy Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Safety Syringe Market

  • 20.1. Spain Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Safety Syringe Market

  • 21.1. Eastern Europe Safety Syringe Market Overview
  • 21.2. Eastern Europe Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Safety Syringe Market

  • 22.1. Russia Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Safety Syringe Market

  • 23.1. North America Safety Syringe Market Overview
  • 23.2. North America Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Safety Syringe Market

  • 24.1. USA Safety Syringe Market Overview
  • 24.2. USA Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Safety Syringe Market

  • 25.1. Canada Safety Syringe Market Overview
  • 25.2. Canada Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Safety Syringe Market

  • 26.1. South America Safety Syringe Market Overview
  • 26.2. South America Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Safety Syringe Market

  • 27.1. Brazil Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Safety Syringe Market

  • 28.1. Middle East Safety Syringe Market Overview
  • 28.2. Middle East Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Safety Syringe Market

  • 29.1. Africa Safety Syringe Market Overview
  • 29.2. Africa Safety Syringe Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Safety Syringe Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Safety Syringe Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Safety Syringe Market Competitive Landscape And Company Profiles

  • 30.1. Safety Syringe Market Competitive Landscape
  • 30.2. Safety Syringe Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Retractable Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novo Nordisk A/s Overview, Products and Services, Strategy and Financial Analysis

31. Safety Syringe Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. Baxter International Inc.
  • 31.3. Boston Scientific Corporation
  • 31.4. Medline Industries LP
  • 31.5. Terumo Corporation
  • 31.6. B. Braun Melsungen AG
  • 31.7. West Pharmaceutical Services Inc.
  • 31.8. Fresenius Kabi AG
  • 31.9. Nemera
  • 31.10. Smiths Medical International Ltd.
  • 31.11. Nipro Medical Corporation
  • 31.12. Henke-Sass Wolf GmbH
  • 31.13. Revolutions Medical Inc.
  • 31.14. Sol-Millennium Inc.
  • 31.15. UltiMed Inc.

32. Global Safety Syringe Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Safety Syringe Market

34. Recent Developments In The Safety Syringe Market

35. Safety Syringe Market High Potential Countries, Segments and Strategies

  • 35.1 Safety Syringe Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Safety Syringe Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Safety Syringe Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer